Hospital Pharmacy - December 2017 - 777

777

Sharma et al.

Figure 2. Trend of lumbar spine surgery by age categories.
Table 2. Surgery Type by Age Categories.
Age, y

Fusion, n (%)

Laminectomy, n (%)

Discectomy, n (%)

Total, n (%)

21 (8.5)
48 (15.1)
121 (30.7)
230 (51.7)
437 (69.6)
857 (42.2)

204 (82.9)
229 (72.0)
179 (45.4)
149 (33.5)
101 (16.1)
862 (42.4)

246 (100.0)
318 (100.0)
394 (100.0)
445 (100.0)
628 (100.0)
2031 (100.0)a

18-34
21 (8.5)
35-44
41 (12.9)
45-54
94 (23.9)
55-64
66 (14.8)
65 and older
90 (14.3)
Total
312 (15.4)
χ2 = 555.2, df = 8, P <.001.
a

Total N is less than 3115 because chi-square analysis did not include those categorized as having multiple surgeries (n = 1084).

Table 3. Proportion of Medication Use by Age Categories.
Age, y

Opioid alone,a n (%)

18-34
166 (10.0)
35-44
228 (13.7)
45-54
354 (21.3)
55-64
437 (26.3)
65 and older
478 (28.7)
Total
1663 (100.0)
χ2 = 58.6, df = 8, P < .001

Opioid combination,b n (%)

Nonopioids,c n (%)

Total, n (%)

127 (9.8)
169 (13.1)
231 (17.9)
290 (22.4)
475 (36.8)
1292 (100.0)

0 (0.0)
0 (0.0)
7 (9.9)
23 (32.4)
41 (57.7)
71 (100.0)

293 (9.7)
397 (13.1)
592 (19.6)
750 (24.8)
994 (32.8)
3026 (100.0)c

a
Include patients who used any dosage form (ie, generic, brand, or salt form) of buprenorphine, butorphanol, codeine, fentanyl, hydromorphone,
hydrocodone, meperidine, methadone, morphine, oxycodone, oxymorphone, remifentanil, and tapentadol.
b
Include patients who used opioids that are in a combined dosage form with drugs such as acetaminophen, aspirin, ibuprofen, and caffeine.
c
Include acetaminophen, aspirin, ibuprofen, and tramadol, alone or in combination with other agents such as caffeine and butalbital.
d
Total N was less than 3115 because chi-square analysis did not include those categorized as using multiple medications (N = 89).

above compared with 45% of patients aged below 55 years.
Similar trends were observed among users of opioid combination therapy (59.2% for patients aged 55 years and above
vs 40.8% for patients aged below 55 years). Nonopioid medications were used mainly for patients 55 years of age and
above (90.1% vs 9.9%).

When data for 2007 versus 2014 were compared (Figure
3), the proportion of LSS patients who used opioid alone
increased for those aged 65 years and above (24.3% vs
30.1%), 55 to 64 years (26.1% vs 32.2%), and 35 to 44 years
(7.8% vs 13.3%), whereas it decreased for those aged 45 to 54
years (29.6% vs 20.3%) and 18 to 34 years (12.2% vs 4.2%).



Table of Contents for the Digital Edition of Hospital Pharmacy - December 2017

Knowing What Is Coming: The Importance of Monitoring the Pharmaceutical Pipeline
In Reply to “Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital”
Letter to the Editor on “Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options”
Response to Letter to the Editor on “Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options”
Commentary: Exploring Novel Approaches to Staff Rewards and Recognition
Edaravone
Pharmaceutical Pipeline Update
BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer’s Disease
Direct and Indirect Remuneration Fees: The Controversy Continues
Factors Associated With Burnout Among US Hospital Clinical Pharmacy Practitioners: Results of a Nationwide Pilot Survey
In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes
Evaluation of Insulin Use and Hypoglycemia in Hospitalized Elderly Patients
Production Standard and Stability of Compounded del Nido Cardioplegia Solution
Lumbar Spine Surgeries and Medication Usage During Hospital Stay: One-Center Perspective
Hospital Pharmacy - December 2017 - 713
Hospital Pharmacy - December 2017 - 714
Hospital Pharmacy - December 2017 - 715
Hospital Pharmacy - December 2017 - 716
Hospital Pharmacy - December 2017 - 717
Hospital Pharmacy - December 2017 - 718
Hospital Pharmacy - December 2017 - 719
Hospital Pharmacy - December 2017 - 720
Hospital Pharmacy - December 2017 - Knowing What Is Coming: The Importance of Monitoring the Pharmaceutical Pipeline
Hospital Pharmacy - December 2017 - 722
Hospital Pharmacy - December 2017 - In Reply to “Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital”
Hospital Pharmacy - December 2017 - 724
Hospital Pharmacy - December 2017 - Letter to the Editor on “Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options”
Hospital Pharmacy - December 2017 - 726
Hospital Pharmacy - December 2017 - Response to Letter to the Editor on “Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options”
Hospital Pharmacy - December 2017 - 728
Hospital Pharmacy - December 2017 - Commentary: Exploring Novel Approaches to Staff Rewards and Recognition
Hospital Pharmacy - December 2017 - 730
Hospital Pharmacy - December 2017 - 731
Hospital Pharmacy - December 2017 - Edaravone
Hospital Pharmacy - December 2017 - 733
Hospital Pharmacy - December 2017 - 734
Hospital Pharmacy - December 2017 - 735
Hospital Pharmacy - December 2017 - 736
Hospital Pharmacy - December 2017 - BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer’s Disease
Hospital Pharmacy - December 2017 - 738
Hospital Pharmacy - December 2017 - 739
Hospital Pharmacy - December 2017 - Direct and Indirect Remuneration Fees: The Controversy Continues
Hospital Pharmacy - December 2017 - 741
Hospital Pharmacy - December 2017 - Factors Associated With Burnout Among US Hospital Clinical Pharmacy Practitioners: Results of a Nationwide Pilot Survey
Hospital Pharmacy - December 2017 - 743
Hospital Pharmacy - December 2017 - 744
Hospital Pharmacy - December 2017 - 745
Hospital Pharmacy - December 2017 - 746
Hospital Pharmacy - December 2017 - 747
Hospital Pharmacy - December 2017 - 748
Hospital Pharmacy - December 2017 - 749
Hospital Pharmacy - December 2017 - 750
Hospital Pharmacy - December 2017 - 751
Hospital Pharmacy - December 2017 - In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes
Hospital Pharmacy - December 2017 - 753
Hospital Pharmacy - December 2017 - 754
Hospital Pharmacy - December 2017 - 755
Hospital Pharmacy - December 2017 - 756
Hospital Pharmacy - December 2017 - 757
Hospital Pharmacy - December 2017 - 758
Hospital Pharmacy - December 2017 - 759
Hospital Pharmacy - December 2017 - 760
Hospital Pharmacy - December 2017 - Evaluation of Insulin Use and Hypoglycemia in Hospitalized Elderly Patients
Hospital Pharmacy - December 2017 - 762
Hospital Pharmacy - December 2017 - 763
Hospital Pharmacy - December 2017 - 764
Hospital Pharmacy - December 2017 - 765
Hospital Pharmacy - December 2017 - Production Standard and Stability of Compounded del Nido Cardioplegia Solution
Hospital Pharmacy - December 2017 - 767
Hospital Pharmacy - December 2017 - 768
Hospital Pharmacy - December 2017 - 769
Hospital Pharmacy - December 2017 - 770
Hospital Pharmacy - December 2017 - 771
Hospital Pharmacy - December 2017 - 772
Hospital Pharmacy - December 2017 - 773
Hospital Pharmacy - December 2017 - Lumbar Spine Surgeries and Medication Usage During Hospital Stay: One-Center Perspective
Hospital Pharmacy - December 2017 - 775
Hospital Pharmacy - December 2017 - 776
Hospital Pharmacy - December 2017 - 777
Hospital Pharmacy - December 2017 - 778
Hospital Pharmacy - December 2017 - 779
Hospital Pharmacy - December 2017 - 780
Hospital Pharmacy - December 2017 - 781
Hospital Pharmacy - December 2017 - 782
Hospital Pharmacy - December 2017 - 783
Hospital Pharmacy - December 2017 - 784
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com